Trial Profile
Phase I/II Trial of R115777 in Patients With Recurrent Malignant Glioma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Jul 2018
Price :
$35
*
At a glance
- Drugs Tipifarnib (Primary)
- Indications Anaplastic astrocytoma; Astrocytoma; Glioblastoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- 04 Oct 2005 New trial record.